Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 169,687 shares of JAZZ stock, worth $23.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
169,687
Previous 274,051 38.08%
Holding current value
$23.9 Million
Previous $29.1 Million 23.1%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$105.93 - $131.8 $11.1 Million - $13.8 Million
-104,364 Reduced 38.08%
169,687 $22.4 Million
Q2 2025

Aug 14, 2025
BUY
$97.78 - $126.44 $7.52 Million - $9.72 Million
76,877 Added 38.99%
274,051 $29.1 Million
Q1 2025

May 19, 2025
BUY
$120.07 - $144.17 $955,036 - $1.15 Million
7,954 Added 4.2%
197,174 $24.5 Million
Q4 2024

Feb 14, 2025
BUY
$107.32 - $127.74 $1.63 Million - $1.93 Million
15,142 Added 8.7%
189,220 $23.3 Million
Q3 2024

Nov 14, 2024
BUY
$100.57 - $116.37 $10.1 Million - $11.7 Million
100,112 Added 135.35%
174,078 $19.4 Million
Q2 2024

Aug 13, 2024
SELL
$103.94 - $118.98 $17.4 Million - $20 Million
-167,719 Reduced 69.4%
73,966 $7.89 Million
Q1 2024

May 15, 2024
BUY
$115.19 - $132.77 $1.01 Million - $1.17 Million
8,805 Added 3.78%
241,685 $29.1 Million
Q4 2023

Feb 14, 2024
SELL
$114.26 - $136.0 $478,977 - $570,112
-4,192 Reduced 1.77%
232,880 $28.6 Million
Q3 2023

Nov 13, 2023
SELL
$122.0 - $145.31 $7.3 Million - $8.69 Million
-59,825 Reduced 20.15%
237,072 $30.7 Million
Q1 2023

May 15, 2023
SELL
$133.98 - $160.47 $713,309 - $854,342
-5,324 Reduced 1.76%
296,897 $43.4 Million
Q4 2022

Feb 14, 2023
BUY
$129.72 - $159.85 $1.71 Million - $2.11 Million
13,204 Added 4.57%
302,221 $48.1 Million
Q3 2022

Nov 14, 2022
SELL
$126.59 - $161.18 $14,304 - $18,213
-113 Reduced 0.04%
289,017 $38.5 Million
Q2 2022

Aug 12, 2022
SELL
$141.59 - $168.66 $5.5 Million - $6.56 Million
-38,876 Reduced 11.85%
289,130 $45.1 Million
Q1 2022

May 16, 2022
SELL
$129.64 - $160.7 $30.2 Million - $37.4 Million
-232,935 Reduced 41.53%
328,006 $51.1 Million
Q4 2021

Feb 14, 2022
BUY
$119.87 - $145.67 $26.9 Million - $32.6 Million
224,125 Added 66.54%
560,941 $71.5 Million
Q3 2021

Nov 15, 2021
SELL
$128.64 - $184.79 $3.31 Million - $4.75 Million
-25,703 Reduced 7.09%
336,816 $43.9 Million
Q2 2021

Aug 16, 2021
BUY
$160.2 - $186.42 $1.49 Million - $1.73 Million
9,306 Added 2.63%
362,519 $64.4 Million
Q1 2021

May 14, 2021
SELL
$150.19 - $173.5 $5.92 Million - $6.84 Million
-39,435 Reduced 10.04%
353,213 $58.1 Million
Q4 2020

Mar 01, 2021
BUY
$140.71 - $165.05 $1.61 Million - $1.89 Million
11,449 Added 3.0%
392,648 $64.8 Million
Q3 2020

Nov 13, 2020
SELL
$105.46 - $144.13 $3,058 - $4,179
-29 Reduced 0.01%
381,199 $54.4 Million
Q2 2020

Aug 14, 2020
SELL
$95.68 - $121.88 $2.31 Million - $2.95 Million
-24,175 Reduced 5.96%
381,228 $42.1 Million
Q1 2020

May 15, 2020
SELL
$87.74 - $152.74 $651,908 - $1.13 Million
-7,430 Reduced 1.8%
405,403 $40.4 Million
Q4 2019

Feb 14, 2020
BUY
$117.65 - $153.73 $8.46 Million - $11.1 Million
71,942 Added 21.1%
412,833 $61.6 Million
Q3 2019

Nov 14, 2019
SELL
$125.18 - $143.24 $2.29 Million - $2.62 Million
-18,271 Reduced 5.09%
340,891 $43.7 Million
Q2 2019

Aug 15, 2019
BUY
$125.55 - $144.48 $311,740 - $358,743
2,483 Added 0.7%
359,162 $0
Q1 2019

May 14, 2019
BUY
$121.81 - $142.95 $10.1 Million - $11.8 Million
82,657 Added 30.16%
356,679 $0
Q4 2018

Feb 13, 2019
SELL
$115.94 - $166.74 $684,509 - $984,432
-5,904 Reduced 2.11%
274,022 $34 Million
Q3 2018

Nov 14, 2018
BUY
$161.01 - $180.57 $2.1 Million - $2.36 Million
13,061 Added 4.89%
279,926 $0
Q2 2018

Aug 14, 2018
BUY
$146.33 - $183.18 $5.79 Million - $7.25 Million
39,581 Added 17.41%
266,865 $0
Q1 2018

May 14, 2018
BUY
$135.59 - $157.16 $4.81 Million - $5.58 Million
35,511 Added 18.52%
227,284 $0
Q4 2017

Feb 09, 2018
BUY
$131.06 - $150.39 $2.06 Million - $2.37 Million
15,739 Added 8.94%
191,773 $0
Q3 2017

Nov 13, 2017
BUY
$142.62 - $155.6 $25.1 Million - $27.4 Million
176,034
176,034 $0

Others Institutions Holding JAZZ

# of Institutions
569
Shares Held
61.8M
Call Options Held
856K
Put Options Held
178K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.84B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email